Lai Kai Pharmaceuticals - B (02105) and VASQUE BIO have signed an exclusive licensing agreement for the regions outside of China for LAE118.

Wisdom Financial News APP has learned that Lai Kai Pharmaceutical-B (02105) has announced that on June 9, 2026, the Group signed an exclusive license agreement (license agreement) with Vasque Bio, Inc.